Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 6, 2009, Pages 892-896

  Novais, Antônia Carlos Magalhães ^a   Lopes, Carmen Luci Rodrigues ^b   Reis, Nádia Rúbia da Silva ^b   e Silva, Ágabo Macêdo Costa ^b   Martins, Regina Maria Bringel ^b   Souto, Francisco José Dutra ^c  

^a UNIVERSITY OF CUIABÁ   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c UNIVERSIDADE FEDERAL DE MATO GROSSO   (Brazil)

Author keywords

Epidemiology; HCV epidemiology; HCV prevalence; Hepatitis C virus; Illicit drug users

Indexed keywords

HEPATITIS C VIRUS;

EID: 70350263708     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000600012     Document Type: Article

References (25)

1. Caiaffa WT, Bastos FI, Freitas LL, Mingoti SA, Proietti FA, Carneiro-Proietti AB, Gandolfi D, Doneda D, Projeto AJUDE-Brasil I, Projeto AJUDE-Brasil II 2006. The contribution of two Brazilian multi-center studies to the assessment of HIV and HCV infection and prevention strategies among injecting drug users: the AJUDE-Brasil I and II Projects. Cad Saude Publica 22: 771-782.
2. Campiotto S, Pinho JR, Carrilho FJ, da Silva LC, Souto FJ, Spinelli V, Pereira LM, Coelho HS, Silva AO, Fonseca JC, Rosa H, Lacet CM, Bernardini AP 2005. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 38: 41-49.
3. Cobos Calleja T, Casanueva Gutierrez M, Gonzales J 2003. Perfil de los usuarios de drogas ingresados en un hospital. An Med Interna 20: 8-17.
4. Codes L, de Freitas LA, Santos-Jesus R, Vivitsky L, Silva LK, Trepo C, Reis MG, Paraná R 2003. Comparative study of hepatitis C virus genotypes 1 and 3 in Salvador, Bahia, Brazil. Bra J Infect Dis 7: 409-417.
5. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE 1996. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency and human T-lymphotropic viruses. Am J Public Health 86: 655-661.
6. Ginabreda MGP, Yoshida CFT, Niel C 1997. Genomic characterization of Brazilian hepatitis C virus genotypes 1a and 1b. Braz J Med Biol Res 30: 339-345.
7. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR 2001. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 34: 180-187.
8. Hwang LY, Ross MW, Zack C, Bull L, Rickman K, Holleman M 2000. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 31: 920-926.
9. Kew M, François G, Lavanchy D, Margolis H, Van Damme P, Grob P, Hallauer J, Shouval D, Leroux-Roels G, Meheus A 2004. Prevention of hepatitis C virus infection. J Viral Hepat 11: 198-205.
10. Lanternier F, Roulot D, Bentata M, Pol S, Viard JP, Gordien E, Jeantils V, Ziol M, Lortholary O 2007. Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis. Gastroenterol Clin Biol 31: 822-827.
11. Martins RMB, Teles SA, Freitas NR, Motta-Castro ARC, Souto FJD, Mussi AH 2006. Distribution of hepatitis C virus genotypes among blood donors from Mid-West region of Brazil. Rev Inst Med Trop Sao Paulo 48: 1-3.
12. Matheï C, Buntinx F, Van Damme P 2002. Seroprevalence of hepatitis C markers among intravenous drug users in western European contries: a systematic review. J Viral Hepat 9: 157-173.
13. Memon MI, Memon MA 2002. Hepatitis C: an epidemiological review. J Viral Hepat 9: 84-100.
14. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Gonçales FL Butterworth L, Cooksley G, Gish RG, Beaugrand M, Fay F, Fay O, Gonzalez JE, Martins RM, Dhumeaux D, Vanderborght B, Stuyver L, Sablon E, de Lamballerie X, Pawlotsky JM 2006 Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78: 1296-1303.
15. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ 2000. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 31: 756-762.
16. Oliveira M de L, Bastos FI, Telles PR, Hacker M de A, Oliveira SA, Miguel JC, Yoshida CF 2009a. Epidemiological and genetic analyses of hepatitis C virus transmission among young/short and long-term injecting drug users from Rio de Janeiro, Brazil. J Clin Virol 44: 200-206.
17. Oliveira ML, Yoshida CF, Telles PR, Hacker MA, Oliveira SA, Miguel JC, do O KM, Bastos FI 2009b. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Epidemiol Infect 137: 970-979.
18. Paraná R, Vitvitsky L, Berby F, Portugal M, Cotrim HP, Cavalcante A, Lyra L, Trepó C 2000. HCV infection in Northeastern Brazil: unexpected high prevalence of genotype 3a and absence of African genotypes. Arq Gastroenterol 37: 213-216.
19. Rodríguez OES, Gil MLM, Santana JFH, Cañal JML, Sánchez AMM 1998. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 14: 555-561.
20. Sablon E, Shapiro F 2004. Hepatitis B and C genotyping: methodologies and implications for patient management. J Gastroenterol Hepatol 19: S329-S337.
21. Scheinmann R, Hagana H, Lelutiu-Weinberg C, Stern R, Des Jarlais DC, Floma PL, Strauss S 2007. Non-injection drug use and hepatitis C virus: a systematic review. Drug Alcohol Depend 89: 1-12.
22. Shepard CW, Finelli L, Alter MJ 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
23. Souto FJ, da Silva AG, Yonamine F 2003. Risk of hepatitis among Brazilian ex-soccer players. Mem Inst Oswaldo Cruz 98: 1025-1026.
24. Stark K, Schreier E, Müller R, Wirth D, Driesel G, Bienzle U 1995. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis 27: 331-337.
25. Zocratto KB, Caiaffa WT, Proietti FA, Carneiro-Proietti AB, Mingoti SA, Ribeiro GJ, Projeto AJUDE-Brasil I 2006. HCV and HIV infection and co-infection: injecting drug use and sexual behavior, AJUDE-Brasil I Project. Cad Saude Publica 22: 839-848.